JAMA Study Finds Vast Majority of Requests for Clinical Trial Data Granted

In 2014, BIO members reaffirmed and broadened their commitment to responsibly share data from clinical trials with other researchers, including academic and government researchers, in an effort to support additional efforts to improve public health. A JAMA study released yesterday shows that biopharmaceutical companies are keeping that commitment, approving the vast majority of requests for patient-level data from clinical trials. The study looked at three platforms containing clinical trial data from 14 drug companies. Of the 177 requests that had been processed, 87 percent were approved and fewer than 7 percent were rejected.

You can view the JAMA study here, and the BIO Principles on Clinical Trial Data Sharing here.

Health  |  Email This Post  |  Printer Friendly
Tags: ,

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>